|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 14/72 | (2006.01) |
| (11) | Number of the document | 2379594 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09775072.3 |
| Date of filing the European patent application | 2009-12-18 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-09 |
| (46) | Date of publication of the claims translation | 2017-11-27 |
| (86) | Number | PCT/US2009/068858 |
| Date | 2009-12-18 |
| (87) | Number | WO 2010/075238 |
| Date | 2010-07-01 |
| (30) | Number | Date | Country code |
| 203569 P | 2008-12-23 | US | |
| 264622 P | 2009-11-25 | US |
| (72) |
BOONE, Thomas C., US
BRANKOW, David W., US
GEGG, JR., Colin V., US
HU, Shaw-Fen Sylvia, US
KING, Chadwick T., CA
LU, Hsieng Sen, US
SHI, Licheng, US
XU, Cen, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Žmogaus CGRP receptorių rišantys antikūnai |
| HUMAN CGRP RECEPTOR BINDING ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-11-19 | 17 | 347.00 EUR |
| 2026-12-18 |